Skip to content

Effects of Oral Nutritional Supplementation in Children at Risk of Undernutrition

Effects of Oral Nutritional Supplementation With Dietary Counseling in 24-60 Months Old Children at Risk of Undernutrition

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05239208
Enrollment
330
Registered
2022-02-14
Start date
2022-01-14
Completion date
2022-12-18
Last updated
2023-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Undernutrition

Brief summary

This prospective, randomized, controlled study will evaluate the effects of oral nutritional supplementation plus dietary counseling versus dietary counseling alone in children at nutritional risk.

Interventions

OTHEROral Nutrition Supplement (ONS) Group

Oral nutritional supplement specifically designed for nutritionally-at risk children and dietary counseling

OTHERControl Group

Dietary counseling

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
24 Months to 60 Months
Healthy volunteers
No

Inclusion criteria

* Children 24-60 months old * Undernourished or at risk of undernutrition according to the WHO Growth Standards. * Child's parent(s)/legal guardian (LG) is willing to abstain from giving additional non-study ONS other than the study product during the study intervention period. * Child's parent(s)/LG is able and willing to follow study procedures and record data in parent diary and complete any forms or assessments needed throughout the study. * Child's parent(s)/LG is not planning to relocate during the study period. * Child's parent(s)/LG has voluntarily signed and dated an Informed Consent Form (ICF), approved by an Independent Ethics Committee/Institutional Review Board (IEC/IRB) or other applicable privacy regulation authorization prior to any participation in the study.

Exclusion criteria

* Participant participates in another study that has not been approved as a concomitant study. * Child is known to have galactosemia, be allergic or intolerant to any ingredient found in the study product. * Child is currently drinking an Abbott product(s). * Child had a history of preterm delivery, defined as a birth before 37 completed weeks of gestation as reported by parent(s)/LG. * Child had birth weight \< 2500 g or \> 4000 g. * Child whose either parent has BMI ≥ 27.5 kg/m2 * Child has continuous oral nutrition supplement (ONS) usage for at least 15 days in the past 1 month prior to screening. The standard ONS formula usually has an energy density of at least 1 kcal/mL, containing protein, carbohydrate and/or fat, as well as a wide range of micronutrients to supplement or use as the sole source of nutrition. * Child has current acute or chronic infections including but not restricted to respiratory infections, diarrhea, acute and chronic Hepatitis B or C, HIV infection or tuberculosis. * Child has been diagnosed with the following according to medical records or report by parent(s)/LG or the clinician's judgment: 1. Severe gastrointestinal disorders such as celiac disease, short bowel syndrome, pancreatic insufficiency, or cystic (Exception: Intestinal parasites infection) 2. Neoplastic, renal, hepatic or cardiovascular, hormonal or metabolic disorders, congenital disease or genetic disorders such as atrial or ventricular wall defects, Down's syndrome, or thalassemia 3. Infantile anorexia nervosa, developmental disability, including physical disorders such as cerebral palsy, or developmental delay 4. Disorders of hemoglobin structure, function or synthesis 5. Clinically significant nutritional deficiency requiring specific treatment with another nutritional supplement (other than the study product) as diagnosed by the investigator. 6. Any other clinically significant medical condition, which in the investigator's opinion, makes him or her unsuitable for inclusion in the study.

Design outcomes

Primary

MeasureTime frameDescription
Weight-for-Age Z-ScoreBaseline to 120 DaysChange in weight-for-age z-score

Secondary

MeasureTime frameDescription
HeightBaseline to 240 DaysMeasured in cm
Mid-Upper-Arm Circumference (MUAC)Baseline to 240 DaysMeasured in cm
Weight-for-Height Measurement CalculationsBaseline to 240 DaysWeight-for-height standard z-scores and percentiles
BMI-for-Age Measurement CalculationsBaseline to 240 DaysBMI-for-age standard z-scores and percentiles
WeightBaseline to 240 DaysMeasured in Kg
MUAMC Measurement CalculationsBaseline to 240 DaysMid-upper-arm-circumference-for-age standard z-scores and percentiles
Dietary IntakeBaseline to 240 DaysMeasured by 24-hour dietary recall
AppetiteBaseline to 240 DaysVisual analog scale from Ate Very Little to Ate Very Much
Height-for-Age Measurement CalculationsBaseline to 240 DaysHeight-for-age standard z-scores and percentiles

Other

MeasureTime frameDescription
Blood Biomarkers Amino AcidBaseline to 240 DaysBlood chemistry analysis of amino acid biomarkers
Body CompositionBaseline to 240 DaysMeasured by duel-energy x-ray absorptiometry
Hand Grip StrengthBaseline to 240 DaysMeasured in kg
Blood Biomarkers BoneBaseline to 240 DaysBlood chemistry analysis of bone biomarkers
Bone QualityBaseline to 240 DaysMeasured by duel-energy x-ray absorptiometry
Lower Leg LengthBaseline to 240 DaysMeasured in cm
Adverse Event ReportingBaseline to 240 DaysParent reported adverse events
Healthcare UtilizationBaseline to 240 DaysNumber of sick days, healthcare visits, missed days school, missed days work
Physical ActivityBaseline to 240 DaysVisual analog scale Not Active to Very Active
Child's Healthy GrowthBaseline to 240 DaysParent completed assessment of child's growth
Product PalatabilityStudy Day 1 to Study Day 2401, 5-point scale from Dislike it very much to Like to very much
Child's Sleep AssessmentBaseline to 240 DaysParent reported sleep habits
Early Childhood Behavior QuestionnaireBaseline to 240 Days6, 7-point Likert scale questions scored from Never to Always

Countries

Vietnam

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026